Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason for insulin resistance and beta cell failure. Mice lacking leptin while overexpressing adiponectin showed normalized glucose and insulin levels and dramatically improved glucose as well as positively affected serum triglyceride levels. Therefore, modestly increasing the levels of circulating full-length adiponectin completely rescued the diabetic phenotype in ob/ob mice. They displayed increased expression of PPARgamma target genes and a reduction in macrophage infiltration in adipose tissue and systemic inflammation. As a result, the transgenic mice were morbidly obese, with significantly higher levels of adipose tissue than their ob/ob littermates, leading to an interesting dichotomy of increased fat mass associated with improvement in insulin sensitivity. Based on these data, we propose that adiponectin acts as a peripheral "starvation" signal promoting the storage of triglycerides preferentially in adipose tissue. As a consequence, reduced triglyceride levels in the liver and muscle convey improved systemic insulin sensitivity. These mice therefore represent what we believe is a novel model of morbid obesity associated with an improved metabolic profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Adiponectin, for example, has been shown to induce angiogenesis in hypoxic fat pads and tumors (75,91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Experimental — accuracy not yet measuredIn the citing paper
“These results are comparable to findings in which increasing the capacity of adipose tissue (66) or the liver (67) to incorporate fatty acids into TGs does not cause insulin resistance and can actually prevent HFD-induced insulin resistance (66).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [66]
In the citing paper
“we have previously demonstrated that overexpression of adiponectin in an ob/ob background improves vascularization and expansion of the subcutaneous fat pad in particular (91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationDamiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., & Schibler, U. (2000) · Genes & Development · doi:10.1101/gad.183500 · Cited by 2,394
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationCCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Cited by
Items 501–600 of 996
The adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2014) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52
Self-citationSears, B., & Ricordi, C. (2012) · PubMed · Cited by 79
Hepler, C., Shao, M., Xia, J. Y., Ghaben, A. L., Pearson, M. J., Vishvanath, L., Sharma, A. X., Morley, T. S., Holland, W. L., & Gupta, R. K. (2017) · eLife · doi:10.7554/elife.27669 · Cited by 53
“Transgenic animals overexpressing adiponectin or mitoNEET develop extreme subcutaneous obesity; however, these animals remain metabolically healthy (Kim et al., 2007; Kusminski et al., 2012).”
Yang, J., Guo, Y., Henning, S. M., Chan, B. C., Long, J., Zhong, J., Acín‐Pérez, R., Petcherski, A., Shirihai, O. S., Heber, D., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000091 · Cited by 59
Illesca, P., Valenzuela, R., Espinosa, A., Echeverría, F., Soto-Alarcón, S. A., Ortíz, M., Campos, C., Vargas, R., & Videla, L. A. (2020) · Food & Function · doi:10.1039/d0fo01790f · Cited by 53
Obesity and Pregnancy, the Perfect Metabolic Storm
Corrales, P., Vidal-Puig, A., & Medina-Gómez, G. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00914-5 · Cited by 51
“accumulation in VAT causes deleterious metabolic effects [27].”
BackgroundAdipose Tissue Aging and Metabolic Disorder, and the Impact of Nutritional Interventions
Wang, X., Xu, M., & Li, Y. (2022) · Nutrients · doi:10.3390/nu14153134 · Cited by 67
Moreno‐Navarrete, J. M., Ortega, F. J., Serrano, M., Rodríguez‐Hermosa, J. I., Ricart, W., Mingrone, G., & Fernández‐Real, J. M. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.171 · Cited by 56
Jung, J., & Kim, H. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.048 · Cited by 52
“An increase in serum adiponectin level stimulates the activation of AMPK, fatty acid oxidation and glucose intake improving insulin resistance (Kim et al., 2007).”
BackgroundAdiponectin: no longer the lone soul in the fight against insulin resistance?
Davis, K. E., & Scherer, P. E. (2008) · Biochemical Journal · doi:10.1042/bj20082033 · Cited by 53
Self-citationArnaboldi, L., & Corsini, A. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(14)70002-9 · Cited by 55
“AKT, LKB1) – sphingolipid pathway [134,135].”
BackgroundSchöttl, T., Kappler, L., Braun, K., Fromme, T., & Klingenspor, M. (2014) · Endocrinology · doi:10.1210/en.2014-1689 · Cited by 50
“Concordantly, visceral mass gain is a well-known risk factor for insulin resistance and type 2 diabetes (4–7) while expansion of subcutaneous adipose tissue even prevents the development of insulin resistance associated with obesity in laboratory mice (51).”
BackgroundEgger, G., & Dixon, J. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00542.x · Cited by 50
Aldehyde Dehydrogenase 1A1: Friend or Foe to Female Metabolism?
Petrosino, J. M., DiSilvestro, D. J., & Ziouzenkova, O. (2014) · Nutrients · doi:10.3390/nu6030950 · Cited by 55
“VF and SF produce dissimilar levels of signaling molecules, including hormones and adipokines, that can further modify fat distribution patterns [98–100].”
BackgroundSalles, J., Tardif, N., Landrier, J., Mothe‐Satney, I., Guillet, C., Vaysse, C., Combaret, L., Giraudet, C., Patrac, V., Bertrand‐Michel, J., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.001 · Cited by 56
“According to these observations in humans, different transgenic rodent models can develop obesity yet remain protected from IR [48,49].”
BackgroundOxidative Stress Regulates Adipocyte Apolipoprotein E and Suppresses Its Expression in Obesity
Espiritu, D. J. D., & Mazzone, T. (2008) · Diabetes · doi:10.2337/db08-0592 · Cited by 58
“For example, reduced TGRL lipid deposition in adipose tissue resulting from reduced adipocyte apoE expression (such as that observed in obesity) could favor lipid delivery to liver and muscle, where deposition of this lipid has been implicated in producing tissuespecific insulin resistance (32-35).”
BackgroundRegulation of Obesity and Metabolic Complications by Gamma and Delta Tocotrienols
Zhao, L., Fang, X., Marshall, M. R., & Chung, S. (2016) · Molecules · doi:10.3390/molecules21030344 · Cited by 53
“Fat cell apoptosis is often concurrent with inhibition in adipogenesis [81,88].”
BackgroundKusminski, C. M., Ghaben, A. L., Morley, T. S., Samms, R. J., Adams, A. C., An, Y., Johnson, J. A., Joffin, N., Onodera, T., Crewe, C., et al. (2020) · Diabetes · doi:10.2337/db19-0327 · Cited by 50
“Fat-specific adiponectin-overexpressing mice are highly sensitive to b3-adrenergic receptor (AR) agonist treatment (16).”
BackgroundSelf-citationMolecular Mechanisms of Insulin Resistance in Diabetes
Kouidhi, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_19 · Cited by 57
Physiological significance of heme oxygenase in hypertension
Cao, J. J., Inoue, K., Li, X., Drummond, G., & Abraham, N. G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.025 · Cited by 51
“Similar to obesity, insulin resistance and dyslipidaemia, hypertension is associated with low levels of circulating adiponectin (Wang and Scherer, 2008; Adamczak et al., 2003; Iwashima et al., 2004; Kim et al., 2007; Della et al., 2005).”
BackgroundYue, L., & Mazzone, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808482200 · Cited by 49
Nat1 Deficiency Is Associated with Mitochondrial Dysfunction and Exercise Intolerance in Mice
Chennamsetty, I., Coronado, M., Contrepois, K., Keller, M. P., Carcamo-Orive, I., Sandin, J., Fajardo, G., Whittle, A. J., Fathzadeh, M., Snyder, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.005 · Cited by 49
“At a tissue level, while decreased insulin-mediated glucose uptake in skeletal muscle is a cardinal feature of IR, it is also apparent that IR and dysfunctional adipose tissue are inextricably intertwined and co-occur in type 2 diabetes mellitus (T2D) and cardiovascular disease (Kim et al., 2007; Wang et al., 2005; We…”
BackgroundSerra, M. C., Ryan, A. S., & Goldberg, A. P. (2016) · Obesity Science & Practice · doi:10.1002/osp4.86 · Cited by 51
Zhao, M., & Chen, X. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00601.2014 · Cited by 56
The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity
Yasui, M., Tamura, Y., Minami, M., Higuchi, S., Fujikawa, R., Ikedo, T., Nagata, M., Arai, H., Murayama, T., & Yokode, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136304 · Cited by 53
“Adiponectin, in turn, suppresses macrophage infiltration into adipose tissue and promotes alternative M2 macrophage activation [33,34].”
BackgroundAllister, C. A., Liu, L.-F., Lamendola, C. A., Craig, C. M., Cushman, S. W., Hellerstein, M. K., & McLaughlin, T. L. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m052860 · Cited by 48
Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance
Han, S. J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E., & Leonetti, D. L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01703 · Cited by 51
“(18) reported that a leptin-deficient mouse model with overexpression of adiponectin showed a decrease in visceral fat and increase in subcutaneous fat and improved insulin sensitivity.”
BackgroundMinireview: Obesity and LipOdystrophy—Where Do the Circles Intersect?
Chehab, F. F. (2008) · Endocrinology · doi:10.1210/en.2007-1355 · Cited by 51
“Recently, adiponectin overexpression in the leptin-deficient ob/ob mouse was shown to rescue its diabetic phenotype while paradoxically exacerbating its obesity (52), thus offering a mechanism to explain the heterogeneity of diabetes among obese individuals and for its potential use in the treatment of hyperglycemia.”
Traditional Anthropometric Parameters Still Predict Metabolic Disorders in Women With Severe Obesity
Ledoux, S., Coupaye, M., Essig, M., Msika, S., Roy, C., Queguiner, I., Clerici, C., & Larger, E. (2010) · Obesity · doi:10.1038/oby.2009.349 · Cited by 48
“This protective role of SAT seems to be intrinsic, independent on its location, at least in animal models in which SAT expansion or SAT transplantation to the visceral cavity improves insulin sensitivity (10,11).”
BackgroundD’Souza, K., Mercer, A., Mawhinney, H., Pulinilkunnil, T., Udenigwe, C. C., & Kienesberger, P. C. (2020) · Nutrients · doi:10.3390/nu12020425 · Cited by 47
“The inability of WAT to effectively expand in the presence of excess nutrients promotes ectopic lipid accumulation in tissues such as skeletal muscle [5].”
BackgroundInsulin sparing action of Adenovirus 36 and its E4orf1 protein
Dhurandhar, N. V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.006 · Cited by 49
“transporter Glut4 (Shepherd, Gnudi, Tozzo, Yang, Leach, & Kahn, 1993), adipokines adiponectin, or Tartrate resistant acid phosphatase (TRAP) (Kim et al., 2007; Lang et al., 2008).”
Raso, G. M., Santoro, A. N., Russo, R., Simeoli, R., Paciello, O., Carlo, C. D., Diano, S., Calignano, A., & Meli, R. (2014) · Endocrinology · doi:10.1210/en.2013-1823 · Cited by 54
Virtue, S., Petkevicius, K., Moreno-Navarrete, J. M., Jenkins, B., Hart, D., Dale, M., Koulman, A., Fernández-Real, J. M., & Vidal-Puig, A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.063 · Cited by 47
Obesity and Adipose Tissue Dysfunction: From Pediatrics to Adults
Menendez, A., Wanczyk, H., Walker, J. M., Zhou, B., Santos, M., & Finck, C. M. (2022) · Genes · doi:10.3390/genes13101866 · Cited by 59
“B cells can also promote an alteration of the adipocytes by hypertrophy [92].”
BackgroundPark, H. T., Lee, E. S., Cheon, Y., Lee, D. R., Yang, K., Kim, Y. T., Hur, J. Y., Kim, S. H., Lee, K. W., & Kim, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04141.x · Cited by 53
The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations
Wiggins, K., Smith, M. A., & Schultz‐Cherry, S. (2021) · Viruses · doi:10.3390/v13061109 · Cited by 54
“Overexpression of anti-inflammatory adiponectin in transgenic genetically obese mice improves their metabolic health by normalizing glucose, insulin, and triglyceride levels, despite markedly increased subcutaneous fat mass [74] (Table 1).”
BackgroundOn the Immunometabolic Role of NF-κB in Adipocytes
Griffin, M. J. (2022) · Immunometabolism · doi:10.20900/immunometab20220003 · Cited by 52
Parker, J., Nakamura, K., Silver, M., Zuriaga, M. A., MacLauchlan, S., Aprahamian, T. R., & Walsh, K. X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548115 · Cited by 48
“Conversely, the overexpression of adiponectin alleviates metabolic dysfunction independent of weight loss in both genetic and diet-induced models of obesity (8, 9).”
BackgroundBuqué, X., Cano, A., Miquilena-Colina, M. E., García‐Monzón, C., Ochoa, B., & Aspichueta, P. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00653.2011 · Cited by 55
Heme Bound Amylin: Spectroscopic Characterization, Reactivity, and Relevance to Type 2 Diabetes
Mukherjee, S., & Dey, S. G. (2013) · Inorganic Chemistry · doi:10.1021/ic4001413 · Cited by 46
Grape pomace extract induced beige cells in white adipose tissue from rats and in 3T3-L1 adipocytes
Lanzi, C. R., Perdicaro, D. J., Landa, M. S., Fontana, A., Antoniolli, A., Miatello, R. M., Oteiza, P. I., & Prieto, M. A. V. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.001 · Cited by 49
“On the other hand, obese mice overexpressing adiponectin present high adipose PPARγ expression, reduced adipose macrophage infiltration, and reduced systemic inflammation with normalized metabolic parameters [43].”
BackgroundLi, M., Trapika, I. G. M. G. S. C., Tang, S. Y. S., Cho, J., Qi, Y., Li, C. G., Li, Y., Yao, M., Yang, D., Liu, B., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.811870 · Cited by 55
“Lipids are stored primarily as relatively inert triglycerides, and triglycerides stored in WAT are unlikely to directly affect insulin function by themselves (74), but increase levels of the bioactive lipid diacylglycerol (DAG).”
BackgroundSelf-citationThe Multi-Level Action of Fatty Acids on Adiponectin Production by Fat Cells
Karki, S., Chakrabarti, P., Huang, G., Wang, H., Farmer, S. R., & Kandror, K. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028146 · Cited by 45
“In further support of this model, adiponectin has been shown to improve insulin resistance associated with obesity [9,10].”
BackgroundBurgess, A., Vanella, L., Bellner, L., Gotlinger, K. H., Falck, J. R., Abraham, N. G., Schwartzman, M. L., & Kappas, A. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000337591 · Cited by 46
Lack of “immunological fitness” during fasting in metabolically challenged animals
Asterholm, I. W., McDonald, J., Blanchard, P.-G., Sinha, M., Xiao, Q., Mistry, J., Rutkowski, J. M., Deshaies, Y., Brekken, R. A., & Scherer, P. E. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m021725 · Cited by 45
Self-citationde Farias, J., Maggi, R. M., Tromm, C. B., da Silva, L. A., Luciano, T. F., Marques, S. M. S., Lira, F. S., de Souza, C., & Pinho, R. A. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-134 · Cited by 51
“However, live substances such as adiponectin [10-12] serve as welldocumented insulin sensitizers.”
BackgroundLiu, L., Wan, J., Lang, H., Si, M., Zhu, J., Zhou, Y. G., & Mi, M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.028 · Cited by 45
Liddle, D. M., Hutchinson, A. L., Wellings, H. R., Power, K. A., Robinson, L. E., & Monk, J. M. (2017) · Nutrients · doi:10.3390/nu9121289 · Cited by 51
“inflammatory adipokine levels, and reduced macrophage AT infiltration compared to obese littermates [313].”
BackgroundLourido, F., Quenti, D., Salgado-Canales, D., & Tobar, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-82944-4 · Cited by 51
Contribution of Adipose Tissue to Health Span and Longevity
Huffman, D. M., & Barzilai, N. (2010) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000319991 · Cited by 48
Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation
Chakravarthy, M. V., Zhu, Y., Li, Y., Coleman, T., Pappan, K. L., Marshall, C. A., McDaniel, M. L., & Semenkovich, C. F. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800379-jlr200 · Cited by 46
“Conversely, despite increased adiposity, mice with inactivation of TLR-4 (32), as well as mice with overexpression of adiponectin ( 33 ), have enhanced insulin sensitivity.”
BackgroundObesity: an evolutionary context
Speakman, J. R., & Elmquist, J. K. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac002 · Cited by 53
“In contrast, expansion of subcutaneous depots can be protective against obesity-induced metabolic disturbances [80, 81].”
BackgroundOleate-enriched diet improves insulin sensitivity and restores muscle protein synthesis in old rats
Tardif, N., Salles, J., Landrier, J., Mothe‐Satney, I., Guillet, C., Vaysse, C., Combaret, L., Giraudet, C., Patrac, V., Bertrand‐Michel, J., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.05.009 · Cited by 51
Dankel, S. N., Degerud, E. M., Borkowski, K., Fjære, E., Midtbø, L. K., Haugen, C., Solsvik, M. H., Lavigne, A. M., Liaset, B., Sagen, J. V., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00188.2013 · Cited by 44
Adiponectin Induces A20 Expression in Adipose Tissue to Confer Metabolic Benefit
Hand, L. E., Usán, P., Cooper, G. J. S., Xu, L. Y., Ammori, B. J., Cunningham, P. S., Aghamohammadzadeh, R., Soran, H., Greenstein, A. S., Loudon, A. S. I., et al. (2014) · Diabetes · doi:10.2337/db13-1835 · Cited by 48
“A “safe” increase in adiposity caused by forced adiponectin overexpression in ob/ob mice has previously been reported (41), resulting in animals with significantly more adipose tissue than their ob/ob littermates but with their inflammatory and diabetic phenotype completely reversed.”
Lysyl oxidase and adipose tissue dysfunction
Pastel, E., Price, E., Sjöholm, K., McCulloch, L. J., Rittig, N. F., Liversedge, N., Knight, B., Møller, N., Svensson, P., & Kos, K. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.002 · Cited by 48
Discovery of a novel potent peptide agonist to adiponectin receptor 1
Kim, S., Lee, Y., Kim, J. W., Son, Y.-J., Ma, M. J., Um, J.-H., Kim, N. D., Min, S. H., Kim, D. I., & Kim, B. B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199256 · Cited by 44
Self-citationGrunseich, C., Miller, R. R., Swan, T., Glass, D. J., Mouelhi, M. E., Fornaro, M., Pétricoul, O., Voštiar, I., Roubenoff, R., Meriggioli, M. N., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30320-x · Cited by 45
Loss of transcriptional repression by BCL6 confers insulin sensitivity in the setting of obesity
Senagolage, M. D., Sommars, M. A., Ramachandran, K., Futtner, C. R., Omura, Y., Allred, A. L., Wang, J., Yang, C., Procissi, D., Evans, R. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.074 · Cited by 44
Chagas disease, adipose tissue and the metabolic syndrome
Nagajyothi, F., Desruisseaux, M. S., Weiss, L. M., Chua, S. C., Albanese, C., Machado, F. S., Esper, L., Lisanti, M. P., Teixeira, M. M., Scherer, P. E., et al. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000900028 · Cited by 52
“PPAR-γ is expressed in adipose tissue and reduces the inflammatory process, similar to adiponectin (Nawrocki et al. 2006, Kim et al. 2007).”
BackgroundSelf-citationNew Insights from Rodent Models of Fatty Liver Disease
Maher, J. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3749 · Cited by 48
“In addition, adiponectin treatment (128) or overexpression (45) limits fatty liver disease due to excessive dietary intake.”
BackgroundMechanisms of Liver Injury in Non-Alcoholic Steatohepatitis
Duwaerts, C. C., & Maher, J. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0224-8 · Cited by 46
Laplante, M., Festuccia, W. T., Soucy, G., Blanchard, P.-G., Renaud, A., Berger, J. P., Olivecrona, G., & Deshaies, Y. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90552.2008 · Cited by 43
Self-citationDyslipidemia: Obese or Not Obese—That Is Not the Question
Ipsen, D. H., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0232-9 · Cited by 47
Exercise and Adipose Tissue Immunity: Outrunning Inflammation
Winn, N. C., Cottam, M. A., Wasserman, D. H., & Hasty, A. H. (2021) · Obesity · doi:10.1002/oby.23147 · Cited by 53
Moreno‐Navarrete, J. M., Serrano, M., Sabater, M., Ortega, F. J., Sérino, M., Pueyo, N., Luche, É., Waget, A., Rodríguez‐Hermosa, J. I., Ricart, W., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.10.002 · Cited by 46
“002 positive energy balance with metabolic disturbance is the inability to appropriately expand the adipose tissue [1–3].”
BackgroundCorrenti, J., Juskeviciute, E., Swarup, A., & Hoek, J. B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00395.2013 · Cited by 43
Turer, A. T., Browning, J. D., Ayers, C. R., Das, S. R., Khera, A., Vega, G. L., Grundy, S. M., & Scherer, P. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3305 · Cited by 42
Self-citationEthnic Differences in the Link Between Insulin Resistance and Elevated ALT
DeBoer, M. D., Wiener, R. C., Barnes, B. H., & Gurka, M. J. (2013) · PEDIATRICS · doi:10.1542/peds.2012-3584 · Cited by 44
McMorrow, A. M., Connaughton, R. M., Lithander, F. E., & Roche, H. M. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s002966511400158x · Cited by 50
“Adiponectin was proposed to signal storage of TAG specifically in AT, while reducing TAG levels in liver and muscle, where ectopic lipid accumulation can impair insulin signalling((69)).”
BackgroundInfluentialMoreno‐Navarrete, J. M., Moreno, M., Ortega, F. J., Sabater, M., Xifra, G., Ricart, W., & Fernández‐Real, J. M. (2015) · Obesity · doi:10.1002/oby.21334 · Cited by 45
“associated with obesity-induced metabolic disturbances (1-3).”
The Immune System in Obesity: Developing Paradigms Amidst Inconvenient Truths
Agrawal, M., Kern, P. A., & Nikolajczyk, B. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0917-9 · Cited by 48
Alcalá, M., Calderón‐Domínguez, M., Serra, D., Herrero, L., Ramos, P., & Viana, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186579 · Cited by 42
Luo, P., Dematteo, A., Wang, Z., Zhu, L., Wang, A., Kim, H.-S., Pozzi, A., Stafford, J. M., & Luther, J. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2814-8 · Cited by 41
“These findings are consistent with the emerging hypothesis that certain adipose tissues can serve as a fatty acid depot and prevent ectopic fat accumulation in visceral tissues [44].”
ResultBurgess, A., Vanella, L., Bellner, L., Schwartzman, M. L., & Abraham, N. G. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.10.002 · Cited by 42
“Although, these findings clearly indicate limiting adipocyte size is a prerequisite for healthy metabolic function adipose expansion also leads to a complete normalization of metabolic parameters despite morbid obesity [84].”
BackgroundThe adipokine Retnla modulates cholesterol homeostasis in hyperlipidemic mice
Lee, M., Lim, C.-J., Lee, Y.-H., Park, J., Sonn, S. K., Lee, M.-N., Jung, I., Jeong, S., Jeon, S., Lee, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5410 · Cited by 47
Self-citationMoreno, M., Ortega, F. J., Xifra, G., Ricart, W., Fernández‐Real, J. M., & Moreno‐Navarrete, J. M. (2014) · The FASEB Journal · doi:10.1096/fj.14-258996 · Cited by 45
Cao, J. J., Vecoli, C., Neglia, D., Tavazzi, B., Lazzarino, G., Novelli, M., Masiello, P., Wang, Y., Puri, N., Paolocci, N., et al. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00160 · Cited by 43
Mário, É. G., Santos, S. H. S., Ferreira, A. V. M., Bäder, M., Santos, R. A. S., & Botion, L. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.014 · Cited by 42
Sha, H., Yang, L., Liu, M., Xia, S., Liu, Y., Liu, F., Kersten, S., & Qi, L. (2014) · Diabetes · doi:10.2337/db13-1067 · Cited by 41
“An earlier study showed that adiponectin-TG ob/ob mice gain more weight than ob/ob littermates (36).”
BackgroundLin, J. Z., Rabhi, N., & Farmer, S. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.057 · Cited by 41
“Obesity-associated insulin resistance is caused by ectopic fat accumulation in non-adipose tissues (Kim et al., 2007).”
BackgroundZhang, Y., Alexander Joel Federation, Kim, S., O’Keefe, J., Lun, M., Xiang, D., Brown, J. D., & Steinhauser, M. L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98353 · Cited by 46
Sbraccia, P., D’Adamo, M., & Guglielmi, V. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01109-4 · Cited by 50
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 46
Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes
Lizcano, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921504 · Cited by 47
“Adiponectin induces adipogenesis through an expansion of adipose tissue with the formation of a fat pad that reduces inflammation, maintaining glucose homeostasis with a reduction in insulin resistance (97).”
BackgroundThe Role of Adiponectin during Pregnancy and Gestational Diabetes
Gruber, B. L. M., & Dolinsky, V. W. (2023) · Life · doi:10.3390/life13020301 · Cited by 55
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health
Lecoutre, S., Rebière, C., Maqdasy, S., Lambert, M., Dussaud, S., Abatan, J. B., Dugail, I., Gautier, E. L., Clément, K., & Marcelin, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01071-y · Cited by 59
“…PPARγ agonist treatment 176 or transgenic overexpression of adiponectin in mice have been shown to lead to an increase in subcutaneous adipogenesis 177 , which suggests that subcutaneous APCs retain adipogenic capacity but are constrained in vivo under ‘normal’ experimental conditions of…”
Metabolic Obesity, Adipocytokines, and Inflammatory Markers in Asian Indians—CURES-124
Indulekha, K., Surendar, J., Anjana, R. M., Geetha, L., Gokulakrishnan, K., Pradeepa, R., & Mohan, V. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0202 · Cited by 40
Brd2 Gene Disruption Causes “Metabolically Healthy” Obesity
Wang, F., Deeney, J. T., & Denis, G. V. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00003-1 · Cited by 49
“in adiponectin transgenic mice on the ob/ob (leptin deficient) background (Kim et al., 2007).”
BackgroundInfluentialYerrakalva, D., Mullis, R., & Mant, J. (2015) · Obesity · doi:10.1002/oby.21181 · Cited by 40
“Further, animal models suggest that healthy subjects with obesity have lower liver triglycerides levels and greater storage of triglycerides in adipose tissue improving insulin sensitivity (64,65).”
BackgroundBlanchard, P.-G., Turcotte, V., Côté, M.-P., Gélinas, Y., Nilsson, S. K., Olivecrona, G., Deshaies, Y., & Festuccia, W. T. (2016) · Acta Physiologica · doi:10.1111/apha.12665 · Cited by 42
“…subcutaneous fat (SF) at the expense of VF is thought to play a major role in the insulin-sensitizing action of TZD (Miyazaki et al. 2002), and more generally is regarded as favouring metabolic health in the undesirable but difficult-to-avoid setting of excessive fat accumulation (Kim et al. 2007).”
BackgroundSelf-citationControl of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3
Nagafuku, M., Sato, T., Sato, S., Shimizu, K., Taira, T., & Inokuchi, J. (2014) · Glycobiology · doi:10.1093/glycob/cwu112 · Cited by 42
Qi, Y., Sun, L., & Yang, H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.06.016 · Cited by 42
Kowalska, K., Olejnik, A. M., Zielińska-Wasielica, J., & Olkowicz, M. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.01.040 · Cited by 46
Park, J., Huh, J. Y., Oh, J., Kim, J. I., Han, S. M., Shin, K. C., Jeon, Y. G., Choe, S. S., Park, J., & Kim, J. B. (2019) · Genes & Development · doi:10.1101/gad.329557.119 · Cited by 45
“Genetic and pharmacologic stimulation of adipocyte hyperplasia could suppress unhealthy adipose tissue remodeling and improve metabolic phenotypes (Shepherd et al. 1993; Berg et al. 2001; Kim et al. 2007; Kusminski et al. 2012; Shao et al. 2018).”
BackgroundSelf-citationCastro‐Barquero, S., Casas, R. M., Rimm, E. B., Tresserra‐Rimbau, A., Romaguera, D., Martínez, J. A., Salas‐Salvadó, J., Martínez‐González, M. Á., Vidal, J., Ruiz‐Canela, M., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200264 · Cited by 46
Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease
Morabito, M. V., Berman, D. E., Schneider, R. T., Zhang, Y., Leibel, R. L., & Small, S. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.12.017 · Cited by 39
Borges, M. C., Oliveira, I. O., Freitas, D. F., Horta, B. L., Ong, K. K., Gigante, D. P., & Barros, A. J. D. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx022 · Cited by 44
“40 Overproduction of adiponectin in animal models can induce substantial expansion of subcutaneous fat depots, 41 which is consistent with the capacity of adiponectin to activate peroxisome proliferator activator receptor (PPAR)- c , a key transcription factor of adipogenesis.”
BackgroundMonk, J. M., Liddle, D. M., Hutchinson, A. L., Wu, W., Lepp, D., David, W. L., Robinson, L. E., & Power, K. A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.07.007 · Cited by 44
A comparative review of intelectins
Chen, L., Li, J., & Yang, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12882 · Cited by 44
Metadata
- Authors
- Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., Jelicks, L. A., Mehler, M. F., Hui, D. Y., Deshaies, Y., Shulman, G. I., Schwartz, G. J., & Scherer, P. E.
- Affiliations
- Université Laval (CA)
- Albert Einstein College of Medicine (US)
- University of Cincinnati (US)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Scherer, Philipp E.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-09-04
- Volume
- 117
- Issue
- 9
- Pages
- 2621-2637
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1950456
- OpenAlex
- W2159346623
- Cited by
- 1,310
- References
- 61
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 67 · 2021: 66 · 2020: 57 · 2019: 64 · 2018: 67 · 2017: 73 · 2016: 62 · 2015: 76 · 2014: 96 · 2013: 115 · 2012: 88
- FWCI
- 58.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- American Heart Association
- National Institutes of Health (DK 59630, DK026687)
- Albert Einstein College of Medicine, Yeshiva University
- National Cancer Institute (R01CA112023)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 59630, R01 DK 55758, R01DK040936, U24DK059635, R01DK055758, DK026687, R01DK066618, U24DK059630, R24DK071030, R21DK075887, R24-DK071030-01, P30DK026687)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- adiponectin, leptin deficiency, ob/ob mice, morbid obesity, insulin resistance, adipose tissue expansion, ectopic fat deposition, PPARγ target genes, macrophage infiltration, systemic inflammation, triglyceride storage, beta-cell failure, metabolic profile
- MeSH terms
- Adipose Tissue, Animals, Animal Feed, Diglycerides, Fats, Gene Expression Regulation, Immunohistochemistry, Insulin, Insulin Resistance, Islets of Langerhans, Lipoproteins, Liver, Macrophages, Mice, Transgenic, Obesity, Organ Size, Phenotype, Triglycerides, Leptin, PPAR gamma, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.